Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling…